Personal information

Other IDs

Scopus Author ID: 24393781900
Loop profile: 1641068
SciProfiles: 1219927

Activities

Collapse all

Employment (2)

Neuregenix Ltd: Birmingham, GB

2020-03-21 to present | Chief Scientific Officer (R&D)
Employment
Source: Self-asserted source
Ann Logan

Axolotl Consulting Ltd: Worcester, GB

2020-03-21 to present | Chief Scientific Officer (R&D)
Employment
Source: Self-asserted source
Ann Logan

Professional activities (1)

University of Warwick: Coventry, West Midlands, GB

2020-09-01 | Honorary Professor of Regenerative Medicine (Biomedical Sciences)
Distinction
Source: Self-asserted source
Ann Logan

Funding (4)

Development of a synthetic flowable dressing that prevents corneal scarring

Source: Self-asserted source
Ann Logan via DimensionsWizard

The molecular control of glial progenitor proliferation in Drosophila and mammals: investigation of Prox1 conditional knock-out mutant mice.

Source: Self-asserted source
Ann Logan via DimensionsWizard

The molecular control of glial progenitor proliferation in Drosophila and mammals

2010-01-04 to 2013-06-29 | Grant
Biotechnology and Biological Sciences Research Council (Swindon, GB)
URL: https://grants.uberresearch.com/501100000268/53CA02D0-866C-4415-974E-3310A9130C00/The-molecular-control-of-glial-progenitor-proliferation-in-Drosophila-and-mammals
GRANT_NUMBER: BB/H002278/1
Source: Self-asserted source
Ann Logan via DimensionsWizard

Expression of growth inhibitory ligand receptors, proteinases and proteinase inhibitors in the regenerating adult rat optic nerve.

Source: Self-asserted source
Ann Logan via DimensionsWizard
How many people are using ORCID?